[HTML][HTML] Haploidentical hematopoietic cell transplantation for myelofibrosis in the ruxolitinib era
M Gambella, S Bregante, AM Raiola, R Varaldo… - … and Cellular Therapy, 2023 - Elsevier
Haploidentical stem cell transplantation is a viable strategy in the absence of an HLA-
identical donor, but in myelofibrosis (MF), concerns may rise due to the risk of graft failure …
identical donor, but in myelofibrosis (MF), concerns may rise due to the risk of graft failure …
[HTML][HTML] Is Haploidentical Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide Feasible in Sub-Saharan Africa?
JR du Toit, A Mcdonald, D Brittain, M Cass… - … and cellular therapy, 2021 - Elsevier
Identifying a suitable volunteer unrelated donor (UD) in South Africa is challenging due to
the highly diverse ethnic groups and mixed-race populations in this region. Haploidentical …
the highly diverse ethnic groups and mixed-race populations in this region. Haploidentical …